Characterization of absorbable collagen sponges as recombinant human bone morphogenetic protein-2 carriers

被引:42
|
作者
Friess, W
Uludag, H
Foskett, S
Biron, R
Sargeant, C
机构
[1] Univ Erlangen Nurnberg, Dept Pharmaceut Technol, D-91058 Erlangen, Germany
[2] Univ Alberta, Dept Biomed Engn, Edmonton, AB T6G 2G3, Canada
[3] Genet Inst Inc, Andover, MA 01810 USA
关键词
collagen; bone morphogenetic protein; sterilization; crosslinking;
D O I
10.1016/S0378-5173(99)00128-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For clinical use recombinant human bone morphogenetic protein-2 (rhBMP-2) is soaked onto an absorbable collagen sponge (ACS) for bone regeneration. Therefore, loss of rhBMP-2 upon mechanical handling during implantation and a potential effect of the carrier on in vivo retention is of interest. The interactions between drug and carrier were looked at from the application mode and the amount of protein which can be mechanically expressed from the combination was investigated. The results indicated that rhBMP-2 binds to the collagen system. The most hydrophilic double extended homodimer showed the least binding affinity to ACS. By extending the waiting time between soaking and implantation, protein incorporation could be increased. In addition, the amount of rhBMP-2 which could be expressed was reduced by heavier ACS material and allowed for a shorter waiting period, especially at lower rhBMP-2 concentration. Crosslinking of ACS with formaldehyde led to reduced binding of rhBMP-2 to collagen either by direct hindrance of binding or reduction in swelling and number of binding sites available. Higher product pH or anion concentration enabled to increase rhBMP-2 incorporation but was limited by the potential precipitation of rhBMP-2. Despite a variety of chemical changes of ACS by ethylene oxide sterilization incorporation was not changed significantly. The in vivo release kinetics of I-125-rhBMP-2 from the collagen sponge were studied using a rat ectopic implant model. The ACS/rhBMP-2 systems tested demonstrated small but significant differences in the in vivo retention of rhBMP-2. Consequently, it is important to have as little variability in pH, anion concentration, crosslinking, and ACS mass as possible to achieve consistent or maximum binding and to avoid rhBMP-2 precipitation. Furthermore, these characteristics can be important for other in vivo applications. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:51 / 60
页数:10
相关论文
共 50 条
  • [41] Effects of recombinant human bone morphogenetic protein-2 on differentiation of cells isolated from human bone, muscle, and skin
    Kawasaki, K
    Aihara, M
    Honmo, J
    Sakurai, S
    Fujimaki, Y
    Sakamoto, K
    Fujimaki, E
    Wozney, JM
    Yamaguchi, A
    BONE, 1998, 23 (03) : 223 - 231
  • [42] Clinical Applications of Recombinant Human Bone Morphogenetic Protein-2 for Bone Augmentation Before Dental Implant Placement
    Misch, Craig
    Wang, Hom-Lay
    CLINICAL ADVANCES IN PERIODONTICS, 2011, 1 (02): : 118 - 131
  • [43] Enhancement by recombinant human bone morphogenetic protein-2 of bone formation by means of porous hydroxyapatite in mandibular bone defects
    Yoshida, K
    Bessho, K
    Fujimura, K
    Konishi, Y
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    JOURNAL OF DENTAL RESEARCH, 1999, 78 (09) : 1505 - 1510
  • [44] A comparative study of polycaprolactone-hydroxyapatite scaffold and collagen membrane carriers for recombinant human bone morphogenic protein-2 for guided bone regeneration
    Rittipakorn, Pawornwan
    Thuaksuban, Nuttawut
    Mai-ngam, Katanchalee
    Charoenla, Satrawut
    INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS, 2022, 71 (01) : 58 - 71
  • [45] Functional reconstruction of the non-human primate mandible using recombinant human bone morphogenetic protein-2
    Marukawa, E
    Asahina, I
    Oda, M
    Seto, I
    Alam, M
    Enomoto, S
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2002, 31 (03) : 287 - 295
  • [46] Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2
    Chen, Bing
    Lin, Hang
    Wang, Jianhua
    Zhao, Yannan
    Wang, Bin
    Zhao, Wenxue
    Sun, Wenjie
    Dai, Jianwu
    BIOMATERIALS, 2007, 28 (06) : 1027 - 1035
  • [47] Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements
    Sandhu, HS
    Kanim, LEA
    Toth, JM
    Kabo, JM
    Liu, D
    Delamarter, RB
    Dawson, EG
    SPINE, 1997, 22 (11) : 1171 - 1180
  • [48] Effect of recombinant human bone morphogenetic protein-2 in an experimental model of spinal fusion in a radiated area
    Ames, CP
    Smith, JS
    Preul, MC
    Crawford, NR
    Kim, GE
    Nottmeier, E
    Chamberlain, R
    Speiser, B
    Sonntag, VKH
    Dickman, CA
    SPINE, 2005, 30 (23) : 2585 - 2592
  • [49] Sinus Floor Augmentation Using Recombinant Human Bone Morphogenetic Protein-2 With Hydroxyapatite: Volume Assessment
    Nam, Jung Woo
    Chee, Young Deok
    Park, Young Bum
    JOURNAL OF CRANIOFACIAL SURGERY, 2020, 31 (04) : 912 - 915
  • [50] Effect of two delivery systems for recombinant human bone morphogenetic protein-2 on periodontal regeneration in vivo
    King, GN
    King, N
    Hughes, FJ
    JOURNAL OF PERIODONTAL RESEARCH, 1998, 33 (04) : 226 - 236